Hull Hans's Form 4 filing
Pliant Therapeutics, Inc. (PLRX) · filed Dec 21, 2022
- Accession no.
- 0001140361-22-046567
- Filed
- Dec 21, 2022
- Trade date
- Dec 19-20, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $167.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hull HansCIK 0001614876 | Officer (Chief Business Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 19, 2022 | Common Stock | AGrant or awardAcquired | +17,578 | $0.00 | $0 | 146,939 | Direct | |
| Dec 20, 2022 | Common Stock | SSaleDisposed | −8,748 | $19.10 | −$167,086.8 | 138,191 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.